Darwin Global Management, Ltd. Verona Pharma PLC Transaction History
Darwin Global Management, Ltd.
- $2.37 Billion
- Q2 2025
A detailed history of Darwin Global Management, Ltd. transactions in Verona Pharma PLC stock. As of the latest transaction made, Darwin Global Management, Ltd. holds 4,129,618 shares of VRNA stock, worth $434 Million. This represents 16.48% of its overall portfolio holdings.
Number of Shares
4,129,618
Previous 3,923,204
5.26%
Holding current value
$434 Million
Previous $249 Million
56.81%
% of portfolio
16.48%
Previous 17.31%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
322Shares Held
76.8MCall Options Held
970KPut Options Held
3.13M-
Janus Henderson Group PLC London, X06.13MShares$645 Million0.3% of portfolio
-
Perceptive Advisors LLC New York, NY5.51MShares$579 Million22.87% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$356 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$321 Million4.43% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.72MShares$286 Million4.88% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.41B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...